United States - English - NLM (National Library of Medicine)

calmco llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - nighttime sleep aid - for the relief of occasional sleeplessness - reduces time to fall asleep if you have difficulty falling asleep

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

dafra pharma gmbh, switzerland - amoxicillin , clavulanic acid - tablet, film-coated - 625

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dafra pharma gmbh - film coated tablets - amoxicillin 875mg, clavulanic acid 125mg - dafraclav® is indicated in the treatment of the following infections caused by the microorganisms indicated below. upper respiratory tract infections (including otitis media and sinusitis) due to beta-lactamase producing strains of haemophilus influenzae and moraxella catarrhalis. lower respiratory tract infections due to beta-lactamase producing strains of haemophilus influenzae and moraxella catarrhalis. skin and skin structure infections due to beta-lactamase producing strains of staphylococcus aureus, escherichia coli and klebsiella spp. urinary tract infections. since dafraclav® contains amoxicillin, it can be used in the treatment of infections caused by bacteria susceptible to ampicillin. additionally, if in a mixed infection a microorganisms is susceptible to ampicillin and the other which is a beta-lactamase producer is susceptible to dafraclav®, such an infection can be treated by the administration of dafraclav® alone, addition of another antibiotic is not required.

Egypt - English - EDA (Egyptian Drug Authority)

lmco pharm -

European Union - English - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer's disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: dextrates; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; hypromellose; polydextrose; macrogol 3350; titanium dioxide; iron oxide yellow; carnauba wax - treatment of major depression.

Egypt - English - EDA (Egyptian Drug Authority)

lmco pharma - sulphadimidine sodium 87.6 gm ( eq.to sulphadimidine base 80 gm) + diaverdine 2.5 gm + vitamin k3 3 gm /100gm - injectable solution

Egypt - English - EDA (Egyptian Drug Authority)

lmco pharma - ampicillin trihydrate 346mg ( eq. to ampicillin base 300mg )/1gm - water soluble powder

United States - English - NLM (National Library of Medicine)

calmco llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - pain reliever/fever reducer temporarily: • reduces fever • relieves minor aches and pains due to: • the common cold • flu • headache • sore throat • toothache

United States - English - NLM (National Library of Medicine)

calmco llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - pain reliever/fever reducer temporarily: • reduces fever • relieves minor aches and pains due to: • the common cold • flu • headache • sore throat • toothache